A phase 2, open-label, parallel cohort study of subcutaneous amivantamab in multiple regimens in patients with advanced or metastatic solid tumors including EGFR-mutated non-small cell lung cancer

التفاصيل البيبلوغرافية
العنوان: A phase 2, open-label, parallel cohort study of subcutaneous amivantamab in multiple regimens in patients with advanced or metastatic solid tumors including EGFR-mutated non-small cell lung cancer
المؤلفون: Young, Caitlin, Ahmed, Samreen
المصدر: http://isrctn.comTest/.
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2022
نوع الوثيقة: dataset
اللغة: unknown
DOI: 10.1186/isrctn11527992
الإتاحة: https://doi.org/10.1186/isrctn11527992Test
رقم الانضمام: edsbas.FFD5258C
قاعدة البيانات: BASE